Long-Term Adherence to Etanercept in Treatment Effectiveness of Patients with Spondyloarthritis: 7-Year Data from the Iraq National Registry

INTRODUCTION: The diagnosis and treatment of spondyloarthritis (SpA) is a global challenge, with no cure available. Adherence to treatment with biologic disease-modifying antirheumatic drugs, such as the tumor necrosis factor-α inhibitor etanercept, varies among patients with SpA. Inadequate or poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Younis, Ali Abdulrahman, Al-Hafidh, Ali Hussein, Adnan, Asal, Yasiry, Dina, Abdulateef, Nizar, Gorial, Faiq I., Llamado, Lyndon, AlJabban, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523177/
https://www.ncbi.nlm.nih.gov/pubmed/36178583
http://dx.doi.org/10.1007/s40744-022-00497-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523177/
https://www.ncbi.nlm.nih.gov/pubmed/36178583
http://dx.doi.org/10.1007/s40744-022-00497-y

Ejemplares similares